Novo Nordisk Sues Eli Lilly Over Alleged False Advertising of Zepbound and Mounjaro in GLP-1 Market
Novo Nordisk A/S (NYSE: NVO) announced it has filed a lawsuit against Eli Lilly and...
Legal / IP
Biocytogen Prevails in Shanghai IP Court as Harbour BioMed Patent Infringement Claims Dismissed – RenNano Platform Cleared of Antibody Technology Violations
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (SHA: 688796, HKG: 2315) announced it has received a favorable...
Harbour BioMed Wins $20.2 Million Patent Verdict Against Amgen in Delaware Court
Harbour BioMed (HKG: 2142) announced that a jury in the U.S. District Court for the...
China’s Seven Ministries Issue Revised Pharmaceutical Representative Management Measures to Combat Commercial Bribery and Strengthen Industry Oversight
China’s National Medical Products Administration (NMPA), in coordination with six other regulatory bodies, has jointly...
UPC Appeal Court Reverses Lower Ruling, Imposes Preliminary Injunction on Sinocare’s iCanCGM App in 17 European Countries Following Abbott Patent Claim
Sinocare Inc. (SHE: 300298) disclosed that the Court of Appeal of the Unified Patent Court...
Siemens Healthineers Partners with Shanghai’s Ruijin Hospital on World’s First AI-Powered Liver Fat Quantification Software
Siemens Healthineers AG (ETR: SHL) has entered into a strategic collaboration with Ruijin Hospital, a...
YZY Biopharma Y225 Patent Secures Hemlibra Biosimilar Pathway in China
Wuhan YZY Biopharma Co., Ltd. (HKG: 2496) announced today that its high‑concentration antibody formulation for...
BeOne Medicines Terminates Patent Dispute with AbbVie’s Pharmacyclics Over BTK Inhibitors
BeOne Medicines Ltd. (NASDAQ: ONC; HKG: 6160; SHA: 688235) announced today that it has terminated...
CureVac and GSK Resolve mRNA Vaccine Patent Dispute With BioNTech and Pfizer
CureVac N.V. (NASDAQ: CVAC) announced on August 7, 2025, that it has reached an agreement...
CARsgen Therapeutics Secures European Patent for GPC3 CAR-T Technology After Successful Opposition Proceedings
China-based CARsgen Therapeutics Holdings Ltd (HKG: 2171) announced a favorable outcome in the opposition proceedings...
Harbour BioMed Wins CNIPA Validation of ‘Binding Molecule’ Patent Amid Dispute
China-based Harbour BioMed (HKG: 2142) announced that the China National Intellectual Property Administration (CNIPA) has...
RemeGen Secures 1,827-Day Patent Extension for Telitacicept in China
China-based pharmaceutical firm RemeGen (HKG: 9995) announced that the China National Intellectual Property Administration has...
Biocytogen’s RenMab Platform Wins Japanese Patent, Expanding IP Portfolio
China’s Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) announced that its RenMab platform, a key...
BeiGene Wins USPTO Ruling Invalidating Pharmacyclics’ Patent Claims
BeiGene, Ltd. (NASDAQ: ONC, HKG: 6160, SHA: 688235), a China-based oncology specialist proposing to change...
AccurEdit’s ARTbase-A1 Base Editor Authorized by USPTO
On April 2, 2025, China-based AccurEdit Therapeutics (Suzhou) Co., Ltd., a specialist in gene editing...
AbbVie Sues Genmab Over Alleged Trade Secret Misappropriation in ADC Development
US pharmaceutical giant AbbVie (NYSE: ABBV) has filed a lawsuit in the U.S. District Court...
Shanghai Pharmaceuticals Subsidiary Fined USD23 Million for Anti-Monopoly Violations
China’s Shanghai Pharmaceuticals (SPH, HKG: 2607, SHA: 601607) has disclosed that its subsidiary, Shanghai SINE...
Hainan Poly Pharm Faces Delisting After CSRC Imposes Strict Penalties for Financial Misconduct
China-based Hainan Poly Pharm Co., Ltd (SHE: 300630) was imposed strict administrative penalties by the...
SMPA Suspends Indobufen Procurement After Patent Infringement Verdict
Shanghai’s Sunshine Medical Procurement All-In-One (SMPA) announced the suspension of procurement for indobufen, manufactured by...
AstraZeneca Faces Class Action Lawsuits Over China Legal Issues
AstraZeneca plc (AZ, NASDAQ: AZN) is facing multiple class action lawsuits in the United States...